Home / Business and Economy / Haleon Sales Rise Despite Market Headwinds
Haleon Sales Rise Despite Market Headwinds
30 Jul
Summary
- Haleon reported 3.1% organic sales growth in the second quarter.
- Oral health products strongly fueled the company's sales.
- The company maintained its 2026 growth forecast of 3% to 5%.
British consumer health company Haleon announced its second-quarter results, revealing a 3.1% organic sales growth. This performance aligns with market expectations and was significantly boosted by strong sales in oral health products.
The company's largest market, North America, experienced accelerating growth, supported by expanded distribution and strategic shelf resets. However, Haleon's overall performance was tempered by a weaker-than-usual flu season and a consumer pullback on discretionary items, including smoking alternatives.
Despite these headwinds, Haleon reiterated its financial projections for 2026. The company anticipates achieving organic revenue growth of 3% to 5% and high-single-digit growth in adjusted operating profit by that year.
